Article

Ozempic and lithium: how to discuss the reported toxicity cases

A case series describes lithium level changes in three people after semaglutide. It raises a question for coordinated care without establishing an interaction rate.

3 min read Published Source checked

A lilac glass teardrop balanced on a narrow silver bar
Treomark original AI-generated editorial image

If you take lithium and are considering Ozempic or another semaglutide product, tell both prescribers before the treatment decision. A case series describes two people with lithium toxicity and a third with higher-than-expected lithium levels after semaglutide was introduced. It does not establish how often this happens or prove a direct drug interaction. Lithium’s boxed warning makes the signal worth reviewing together.123

Separate what happened from the proposed explanation

The paper describes three people with bipolar disorder who were taking lithium. Two developed toxicity; the third did not have toxicity but had higher-than-expected lithium levels with clinical adjustments. One case had uncertainty in the semaglutide history. The authors discuss changes in fluid intake or loss, kidney handling and gastrointestinal effects as possible explanations. Three cases can raise a question for a prescriber, but they cannot isolate one mechanism or establish the probability of harm for a new patient.1

Lithium levels can move into a toxic range close to levels used for treatment. The lithium label describes contributing factors such as dehydration and impaired kidney function. Ozempic labeling separately describes gastrointestinal reactions and reports of kidney injury associated with volume depletion. These records explain why changes in symptoms or fluid status deserve a coordinated review. They are not instructions for adjusting either medicine yourself.23

Agree on who gets which information

Bring the same record to both prescribers
InformationReason to share it
Exact medicinesThe teams can identify the labeled formulations and reconcile both prescriptions.
Recent resultsThe prescribers can review trends with the correct clinical context.
New symptomsThese can warrant prompt assessment rather than a routine follow-up.
After-hours contactYou know where to reach a clinician or get urgent help when symptoms occur.

A symptom can belong to more than one record

Some digestive symptoms are listed in the Ozempic label and also appear in the lithium Medication Guide. The overlap matters because a reader cannot tell from nausea alone which problem is occurring. If a visit summary describes a symptom as an expected reaction, make sure the clinician who can interpret the lithium history has the same information. The timing of a new symptom, the exact products involved and a change from your usual pattern can help the two clinicians communicate. None of those observations, by itself, measures a lithium level.123

Ask for a handoff you can actually use

Before treatment, ask which office orders or reviews lithium-related results and how the other prescriber will learn about them. If a visit is through a telehealth program, ask whether you can obtain a written medication summary and which clinician receives questions between visits. If care moves to an urgent setting, the medication list should identify lithium as well as the semaglutide product. The case report’s uncertainty about a product history is an example of why complete records help.12

Get medical help right away for suspected lithium toxicity. New shaking, poor coordination, unusual drowsiness, vomiting or diarrhea are among the symptoms the lithium Medication Guide flags. In the U.S., Poison Control can advise on suspected poisoning at 1-800-222-1222; call 911 for a medical emergency. A weight management program should be able to explain how it will communicate with the clinician who manages lithium.24

Sources

  1. Journal of Clinical Psychopharmacology / original case series. Lithium Toxicity and Altered Clearance Following Initiation of Semaglutide in Patients With Bipolar Disorder: A Case Series and Literature Review. Full case series describes two toxicity cases and a third case with higher-than-expected levels without toxicity. Accessed .
  2. DailyMed / lithium prescribing information. Lithium Oral Solution prescribing information. Boxed warning and Medication Guide explain toxicity, contributing factors and symptoms requiring prompt medical attention. Accessed .
  3. DailyMed / Ozempic prescribing information. OZEMPIC (semaglutide) injection prescribing information. Describes gastrointestinal adverse reactions and kidney injury associated with volume depletion. Accessed .
  4. MedlinePlus. Lithium toxicity. Provides emergency and Poison Control guidance for suspected lithium toxicity. Accessed .
Built from the public records listed above. Spot an error? Report a correction